The World Health Organization (WHO) has introduced updated recommendations for the treatment of children living with HIV, aiming to improve survival rates and make lifesaving medicines more accessible in countries with high HIV burdens.
The revised guidance focuses on simplifying antiretroviral therapy (ART) for infants and children by recommending improved drug formulations, weight-based dosing, and faster access to effective medications. Health experts believe the changes could help thousands of children receive treatment earlier while reducing complications linked to HIV infection.
According to WHO, although significant progress has been made in the global fight against HIV, children remain one of the most underserved groups when it comes to diagnosis and treatment. Many infants are still diagnosed late or face delays in starting lifesaving medication, increasing their risk of severe illness and death.
Millions of Children Continue Living With HIV
WHO estimates that around 1.4 million children under the age of 15 are living with HIV worldwide. While access to treatment has expanded considerably over the past decade, hundreds of thousands of children still do not receive the antiretroviral medicines they need.
Without timely treatment, HIV weakens a child’s immune system, making them more vulnerable to infections such as pneumonia, tuberculosis, and other life-threatening illnesses. Early diagnosis and prompt treatment have been shown to dramatically improve long-term health outcomes.
Health officials say eliminating the treatment gap for children is now one of the highest priorities in the global HIV response.
New Guidelines Promote Simpler and More Effective Care
The updated WHO recommendations encourage countries to adopt newer pediatric HIV medicines that are easier to administer, have fewer side effects, and provide stronger viral suppression.
Among the key changes are:
- Wider use of child-friendly antiretroviral formulations.
- Simplified dosing based on a child’s weight.
- Earlier initiation of treatment immediately after diagnosis.
- Better integration of HIV services into maternal and child healthcare.
- Stronger monitoring to ensure children remain on treatment.
Medical experts say these improvements will make it easier for healthcare workers and caregivers to manage HIV treatment while improving adherence among children.
Early Testing Remains Critical
WHO is urging countries to strengthen early infant diagnosis programs, especially for babies born to mothers living with HIV.
Health authorities recommend that infants exposed to HIV be tested as early as possible after birth, allowing treatment to begin immediately if infection is confirmed. Studies show that starting ART within the first weeks of life significantly reduces the risk of severe illness and improves survival.
Despite advancements in testing technology, many children in low-income countries are still diagnosed months or even years after infection.
Sub-Saharan Africa Bears the Greatest Burden
The majority of children living with HIV reside in sub-Saharan Africa, where healthcare systems continue to face shortages of trained personnel, laboratory services, and pediatric medicines.
Countries such as Nigeria, South Africa, Mozambique, Tanzania, Uganda, and Kenya continue to account for a large share of new pediatric HIV infections.
WHO is encouraging governments and international partners to invest more in maternal healthcare, prevention of mother-to-child transmission, and expanded pediatric HIV services to reduce new infections and improve treatment outcomes.
Importance for Nigeria
Nigeria remains one of the countries with a significant HIV burden. Public health experts say adopting WHO’s updated recommendations could help improve access to treatment for children across the country.
The National Agency for the Control of AIDS (NACA) and healthcare providers have continued efforts to expand HIV testing, treatment, and prevention services, particularly for pregnant women and newborns.
Experts believe that wider availability of child-friendly HIV medicines and earlier diagnosis could substantially reduce HIV-related deaths among Nigerian children.
WHO Calls for Global Commitment
WHO says achieving the global goal of ending AIDS as a public health threat by 2030 will require stronger investment in pediatric HIV care.
The organization is urging governments, healthcare providers, donor agencies, and pharmaceutical manufacturers to work together to ensure that every child living with HIV has access to safe, effective, and affordable treatment.
Health officials emphasize that no child should die from a disease that can be effectively managed with timely diagnosis and proper medication.
